ATS Blue Journal
@ATSBlueEditor
Followers
20K
Following
437
Statuses
7K
Posting content from the American Journal of Respiratory and Critical Care Medicine; follows do not indicate endorsement. #pulmCC #sleepmed #AJRCCM #RespEd #ATS
Joined December 2014
The AJRCCM invites authors to submit their original research on developmental aspects of respiratory disease @atscommunity FIND OUT MORE HERE: SUBMIT HERE:
0
3
1
The Blue Journal thanks Daniel Combs, M.D., for his contribution to the February issue Peer-Driven Intervention for Care Coordination and Adherence Promotion for Obstructive Sleep Apnea @DanielC38525358
0
0
2
Efficacy and Safety of Admilparant, an LPA1 Antagonist, in Pulmonary Fibrosis: A Phase 2 Randomized Clinical Trial @atscommunity 🔗
0
1
1
Targeting Autotaxin and Lysophosphatidic Acid in Pulmonary Fibrosis: Admilparant’s Positive Results Show Continued Promise @atscommunity 🔓 Open Access 🔗
0
0
1
The Blue Journal thanks Laura Colinas, M.D., Ph.D., for her contribution to the February issue Humidified Noninvasive Ventilation versus High-Flow Therapy to Prevent Reintubation in Patients with Obesity
0
0
7
Humidified Noninvasive Ventilation versus High-Flow Therapy to Prevent Reintubation in Patients with Obesity @atscommunity In this trial, the rate of reintubation was not significantly lower with noninvasive ventilation vs high-flow nasal cannula
0
9
23
Prophylactic Noninvasive Ventilation after Extubation of Obese Patients @atscommunity 🔓 Open Access 🔗
0
4
4
The Blue Journal thanks David C. LaFon, M.D., for his contribution to the February issue Serum Immunoglobulin G Levels Are Associated with Risk for Exacerbations: An Analysis of SPIROMICS
0
1
4
Serum Immunoglobulin G Levels Are Associated with Risk for Exacerbations: An Analysis of SPIROMICS @atscommunity 🔗
0
2
2
Best in Class: IgG as a Treatable Trait for Exacerbation Prevention in Chronic Obstructive Pulmonary Disease @atscommunity 🔓 Open Access 🔗
0
15
23
RT @ATSBlueEditor: The AJRCCM invites authors to submit their original research on developmental aspects of respiratory disease @atscommuni…
0
3
0
Thanks to Alec Mushunje, M.D., Ph.D., for his contribution to the February issue Effect of Triple Therapy on Cardiovascular and Severe Cardiopulmonary Events in COPD: A Post Hoc Analysis of a Randomized, Double-Blind, Phase 3 Clinical Trial (ETHOS)
0
1
3
The ATS Breathe Easy Podcast is back! Self-described pulmonary fibrosis warrior and former journalist, Teresa Barnes, joins host and former CNN news anchor Patti Tripathi 🔊
0
0
2
Effect of Triple Therapy on Cardiovascular and Severe Cardiopulmonary Events in Chronic Obstructive Pulmonary Disease: A Post Hoc Analysis of a Randomized, Double-Blind, Phase 3 Clinical Trial (ETHOS) @atscommunity 🔗
0
4
10
🚨 NEW ATS DOCUMENT Interventional Strategies for Children with Progressive Pulmonary Hypertension Despite Optimal Therapy: An Official American Thoracic Society Clinical Practice Guideline 🔗
0
0
0
The Role of Inhaled Corticosteroids in Reducing Cardiovascular Risk: Seeing Is Not Always Believing @atscommunity 🔓 Open Access 🔗
0
3
3
The Blue Journal thanks Vitalii Poberezhets, M.D., Ph.D., for his contribution to the February issue Assessment of Home-based Monitoring in Adults with Chronic Lung Disease: An Official ATS Research Statement
0
0
2
Type 1 Immune Responses Related to Viral Infection Influence Corticosteroid Response in Asthma @atscommunity 🔗
0
3
9
The Blue Journal thanks Ryan D. Coleman, M.D., F.A.A.P., for his contribution to the February issue Interventional Strategies for Children with Progressive Pulmonary Hypertension Despite Optimal Therapy
0
0
1